MedWire News - Psoriasis - Start dose for UV-B psoriasis treatment important for tolerance, not efficacy
Links shared publicly online about this topic.
- 473total visits
MedWire News - Psoriasis - Start dose for UV-B psoriasis treatment important for tolerance, not efficacy
MedWire News Determining the appropriate dose of narrowband ultraviolet-B treatment for psoriasis patients by first working out their minimal erythemal dose does not affect treatment efficacy, but is important for identifying adverse effects, say researchers. MedWire News
View full resource at medwire-news.md
Most Recently Shared on March 12, 2011 at 3:29 pm By:
Start dose for UV-B psoriasis treatment important for tolerance, not efficacy http://bit.ly/gV2Rna #psoriasis
Also Shared By:
Advertisement
National Psoriasis Foundation
@NPF
RT @MedWireNews Start dose for UV-B #psoriasis treatment important for tolerance, not efficacy http://bit.ly/gV2Rna
1 year ago...